Oct. 14, 2003 — Complexed prostate-specific antigen (cPSA) as a single test improved specificity over total PSA, according to the results of a prospective study published in the November issue of the ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Instead of waiting days or even weeks for the result of a prostate-specific antigen (PSA) test, physicians and their patients can now have the information in minutes, thanks to a novel device recently ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

THIS YEAR, IT'S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there's no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty of men who do not have aggressive disease while sometimes missing cancers ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

A recent BBC investigation questioned the accuracy of prostate-specific antigen (PSA) self-tests – rapid at-home tests for men worried about prostate cancer. The BBC analysed five of these tests using ...

Please provide your email address to receive an email when new articles are posted on . A novel blood test was more accurate than PSA screening for identifying patients with high-risk prostate cancer, ...

The prostate health index (PHI) is a blood test that more accurately assesses prostate cancer risk than a PSA test. Early prostate cancer detection can lead to more effective treatment and a better ...